My view remains that MRNA's selloff is actually a good thing. It takes pressure off the stock, which has become what Wall Street-types like to call a "crowded trade" as momentum traders piled on in recent months as the share price ran from $200 to nearly $500.
This post is for paying subscribers only
You might also like...
New Buy! Takeoff for Airline Stocks?
3 min read
Cutting Losses on These Stocks
2 min read
Adding to this "Essential" Holding + Covering Shorts